# clm_3E7B3994881E

subject: Vertex Pharmaceuticals (/record/vertex-pharmaceuticals.md)  
predicate: quarterly_revenue  
value: 858,435,000 United States dollar  
valid_from: 2019-03-31  
valid_to: 2019-06-30  
published: 2019-05-01  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_CDABAE46C981  
last_updated: 2026-11-08  
cite: AsOf. "Vertex Pharmaceuticals quarterly revenue: 858,435,000 United States dollar", as of 2019-03-31 (until 2019-06-30). Claim clm_3E7B3994881E, https://asof.is/claim/clm_3E7B3994881E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/875320/000087532019000019/0000875320-19-000019-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q1 FY2019, filed 2019-05-01  

## Sources

- https://www.sec.gov/Archives/edgar/data/875320/000087532019000019/0000875320-19-000019-index.htm (primary, SEC EDGAR 10-Q Q1 FY2019, published 2019-05-01)

## Supersedes

- [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | quarterly_revenue | 784,535,000 United States dollar | valid 2018-09-30 to 2019-03-31 | conf 0.95 | superseded | superseded_by [clm_3E7B3994881E](/claim/clm_3E7B3994881E.md) | [clm_8E2ABC809D39](/claim/clm_8E2ABC809D39.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.